Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexicon Pharmaceuticals (LXRX) Capital Expenditures: 2009-2024

Historic Capital Expenditures for Lexicon Pharmaceuticals (LXRX) over the last 16 years, with Dec 2024 value amounting to $1.0 million.

  • Lexicon Pharmaceuticals' Capital Expenditures fell 45.93% to $113,000 in Q4 2012 from the same period last year, while for Dec 2012 it was $492,000, marking a year-over-year decrease of 59.20%. This contributed to the annual value of $1.0 million for FY2024, which is 119.36% up from last year.
  • Latest data reveals that Lexicon Pharmaceuticals reported Capital Expenditures of $1.0 million as of FY2024, which was up 119.36% from $470,000 recorded in FY2023.
  • In the past 5 years, Lexicon Pharmaceuticals' Capital Expenditures registered a high of $1.3 million during FY2022, and its lowest value of $87,000 during FY2020.
  • Over the past 3 years, Lexicon Pharmaceuticals' median Capital Expenditures value was $1.0 million (recorded in 2024), while the average stood at $942,333.
  • In the last 5 years, Lexicon Pharmaceuticals' Capital Expenditures soared by 1,303.45% in 2021 and then slumped by 64.56% in 2023.
  • Yearly analysis of 5 years shows Lexicon Pharmaceuticals' Capital Expenditures stood at $87,000 in 2020, then soared by 1,303.45% to $1.2 million in 2021, then rose by 8.60% to $1.3 million in 2022, then plummeted by 64.56% to $470,000 in 2023, then spiked by 119.36% to $1.0 million in 2024.